Alignment Healthcare (NASDAQ:ALHC) Trading 3.1% Higher – Here’s Why

Alignment Healthcare, Inc. (NASDAQ:ALHC)’s stock price traded up 3.1% during trading on Wednesday . The stock traded as high as $19.94 and last traded at $19.8340. 359,842 shares were traded during trading, a decline of 88% from the average session volume of 3,018,192 shares. The stock had previously closed at $19.24.

Key Stores Impacting Alignment Healthcare

Here are the key news stories impacting Alignment Healthcare this week:

• Positive Sentiment: Baird says Alignment is a buy after the recent pullback, a call that can attract value and momentum buyers and support the stock. Baird Buy Note
• Neutral Sentiment: Analyst backdrop remains generally constructive: consensus from MarketBeat shows a “Moderate Buy” stance and a ~$20.35 average target; several firms (JPMorgan, Goldman, KeyCorp) have recent buy/overweight views or raised targets. This provides a baseline of support but not new catalyst. MarketBeat Analyst Summary
• Negative Sentiment: Major insider selling — CEO John Kao sold 605,648 shares (~21.3% reduction, ~$11.35M), and President Dawn Maroney sold 282,070 shares (~16.9%, ~$5.29M). Large, high‑profile dispositions like these often weigh on sentiment and can trigger short‑term selling pressure. Kao SEC Filing
• Negative Sentiment: Additional insider sales from Robert L. Scavo (69,541 sh), Christopher J. Joyce (16,187 sh) and Hyong Kim (12,694 sh) — all at the same ~$18.74 average — add to the overall sell signal and reduce confidence that insider activity is accumulation. Scavo SEC Filing Joyce SEC Filing Kim SEC Filing

Analysts Set New Price Targets

ALHC has been the topic of a number of recent analyst reports. Weiss Ratings restated a “sell (d-)” rating on shares of Alignment Healthcare in a report on Wednesday, October 8th. Zacks Research downgraded shares of Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 28th. Wall Street Zen raised shares of Alignment Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, November 8th. The Goldman Sachs Group reissued a “buy” rating and issued a $22.00 price target on shares of Alignment Healthcare in a report on Monday, November 3rd. Finally, Barclays upped their price objective on shares of Alignment Healthcare from $13.00 to $18.00 and gave the company an “equal weight” rating in a research report on Friday, October 31st. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, three have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $20.35.

Alignment Healthcare Trading Up 3.3%

The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 1.99. The company has a market cap of $3.98 billion, a price-to-earnings ratio of -165.63 and a beta of 1.16. The firm has a 50 day moving average price of $18.22 and a two-hundred day moving average price of $16.22.

Alignment Healthcare (NASDAQ:ALHC) last posted its quarterly earnings data on Thursday, October 30th. The company reported $0.02 earnings per share for the quarter, topping the consensus estimate of ($0.01) by $0.03. Alignment Healthcare had a negative net margin of 0.57% and a negative return on equity of 16.23%. The company had revenue of $993.70 million during the quarter, compared to analysts’ expectations of $980.90 million. During the same period in the prior year, the company posted ($0.14) earnings per share. Alignment Healthcare’s revenue for the quarter was up 43.5% compared to the same quarter last year. As a group, equities analysts forecast that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Insider Activity at Alignment Healthcare

In other Alignment Healthcare news, insider Robert L. Scavo sold 69,541 shares of the business’s stock in a transaction that occurred on Monday, December 29th. The stock was sold at an average price of $18.74, for a total transaction of $1,303,198.34. Following the completion of the sale, the insider directly owned 503,014 shares of the company’s stock, valued at approximately $9,426,482.36. The trade was a 12.15% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Joseph S. Konowiecki sold 25,000 shares of the company’s stock in a transaction on Tuesday, October 28th. The stock was sold at an average price of $18.00, for a total value of $450,000.00. Following the sale, the director owned 1,085,973 shares of the company’s stock, valued at $19,547,514. This trade represents a 2.25% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 1,828,297 shares of company stock worth $33,667,738. 6.60% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Larson Financial Group LLC purchased a new stake in shares of Alignment Healthcare in the third quarter worth about $33,000. SBI Securities Co. Ltd. lifted its stake in Alignment Healthcare by 4,868.9% in the 2nd quarter. SBI Securities Co. Ltd. now owns 3,031 shares of the company’s stock worth $42,000 after purchasing an additional 2,970 shares in the last quarter. KBC Group NV bought a new position in Alignment Healthcare in the 2nd quarter valued at $44,000. Signaturefd LLC grew its position in shares of Alignment Healthcare by 142.6% during the 2nd quarter. Signaturefd LLC now owns 3,768 shares of the company’s stock valued at $53,000 after purchasing an additional 2,215 shares in the last quarter. Finally, Wilmington Savings Fund Society FSB purchased a new position in shares of Alignment Healthcare during the 3rd quarter valued at $53,000. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.